Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Urgent and emergency care

Chief pharmaceutical officer 'hopeful' urgent medicines service will be renewed

Exclusive: Keith Ridge, the chief pharmaceutical officer for England, has said the NHS Urgent Medicine Supply Advanced Service is “proving to be successful” and that “we can’t do without it”.

Keith Ridge, chief pharmaceutical officer

Source: Nadia Attura / Royal Pharmaceutical Society

Keith Ridge, the chief pharmaceutical officer for England, has suggested that that the NHS Urgent Medicine Supply Advanced Service could potentially become a permanent service in the future

Keith Ridge, chief pharmaceutical officer for England, has said it would be “difficult to justify” not renewing the NHS Urgent Medicine Supply Advanced Service (NUMSAS) in community pharmacies as it has become an important part of the services they offer patients.

A pilot of the service — which forwards calls to NHS 111 concerning the urgent supply of medicines to community pharmacies signed up to the scheme — was extended for six months in November 2017 and will run until September 2018. 

The Pharmaceutical Services Negotiating Committee (PSNC) recently said the pilot, which was developed with money from the Pharmacy Integration Fund, was “likely” to be extended. In comments given to The Pharmaceutical Journal, Ridge went even further, suggesting that the service could be made permanent in the future.

Ridge said that the renewal of the service had been discussed and was “going through a process” at NHS England: “It’s proving to be successful, and my view is we can’t do without it, so let’s see what happens in terms of actually signing on the dotted line.”

He added: “I am hopeful and I think, at minimum, it would be an extension of the pilot in terms of running it longer.

“Obviously, the Department [of Health and Social Care] needs to consider where it is with the contractual framework negotiations, but at the same time we have got to ensure that patients still benefit from what is obviously a successful service.

“I would find it difficult to justify taking it away when it’s pretty obvious that it’s going to become an important part of what community pharmacy does.”

An interim evaluation by NHS England in January 2018 found that around one in four patients would have gone without their medicine if a pharmacist had not supplied it.

In its July 2018 summary report for local pharmaceutical committees (LPCs) and contractors, the PSNC said the long-term commissioning of the service may be a subject that could become part of the forthcoming negotiations on a new community pharmacy contract.

It has discussed potential improvements to the scheme with community pharmacy contractors and LPCs, and has drawn up a list that could be discussed with NHS England. These include an IT solution for pharmacies providing the service, which would allow digital referrals to be made from NHS 111; the service being provided on a walk-in basis; and an extension of the service to include referrals from other areas of the health service, such as hospital emergency departments.

Pharmacists and LPCs told the PSNC they felt that NHS 111 could streamline the NUMSAS process, with call-handlers being given training on how to make referrals and giving a verbal explanation to patients of how the service works.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2018.20205286

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 1 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £138.50Buy now
  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 2 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £262.50Buy now
  • International Research in Healthcare

    International Research in Healthcare

    Guidance for students or researchers undertaking a multi-centre research project in health services, medicines use and professional practice.

    £38.00Buy now
  • Drugs in Use

    Drugs in Use

    Optimise drug therapy for your patients. These case studies help you bridge the gap between theoretical medicines knowledge and practical applications.

    £43.00Buy now
  • Injectable Drugs Guide

    Injectable Drugs Guide

    A user friendly, single point of reference for healthcare professionals in the safe and effective administration of injectable medicines.

    £54.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Keith Ridge, chief pharmaceutical officer

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.